Horizon Discovery Expands Cell-Based CRISPR Screening Services
New arrayed B cell CRISPR knockout screening service strengthens support for development of therapeutics for diseases involving the immune system
Cell Lines
Biopharmaceutical Glycan Profiling
Characterizing and profiling glycans is essential for safety and consistency
Ubiquigent Launches a New Service to Facilitate Target Validation of Deubiquitylase (DUB) Enzymes and Determine Compound-DUB Target Engagement and Selectivity of Novel Compounds in Cells
The DUBprofiler-Cell™ assay utilizes activity-based probes to capture active DUBs (i.e. DUBs with reactive catalytic site cysteine residues) within a cell-line or tissue
Horizon Discovery Signs Collaboration and License Agreement with Mammoth Biosciences
Company aims to develop the next generation of engineered CHO cell lines to improve production of biotherapeutics
Horizon Discovery Partners with the Human Protein Atlas
Agreement will expand open access resource, supporting genetic research globally
DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development
New product directs transgene cassettes to most active promoter regions in a given cell inserting multiple copies independently
Sphere Fluidics and PAA Introduce Integrated Microplate Handling and Single Cell Analysis Capabilities
Integration of PAA’s S-LAB with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development
AMSBIO Luciferase Kits Improve Reporter Gene Assays
Once cell lines are finally validated, why jeopardize your results with cheap and low-end detection kits that can impact the reproducibility of your experiments?
Flow Cytometry for Cell Line Development
Picking winners for cell line development